The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.
Matilde CorianòChiara TommasiAnh Thi Lan DinhJazmine NeedhamHala AzizNalinie Joharatnam-HoganNiamh CunninghamJasmin WaterhouseMingze SunFiona TurkesBenedetta PellegrinoSophie McGrathAlicia OkinesMarina PartonNicholas TurnerStephen JohnstonAntonino MusolinoAlistair RingNicolo Matteo Luca BattistiPublished in: Breast cancer research and treatment (2024)
This study supports the interpretation of HER2 status as a possible prognostic and predictive biomarker for HER2-negative eBC, especially among patients with ER+ disease.